Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting

Author:

Ó Ciardha Darach,Blake Anne-Marie,Creane DylanORCID,Callaghan Michael Ó,Darker CatherineORCID

Abstract

ObjectivesThis study aimed to develop and assess the feasibility and cost impact of an intervention involving a practice pharmacist embedded in general practice to improve prescribing safety, deprescribe where appropriate and reduce costs.SettingFour-doctor suburban general practice.ParticipantsInclusion criteria: patients receiving 10+ repeat drugs per month. Exclusion criteria: deceased, <18 years of age, nursing home resident, no longer attending, late-stage life-limiting condition, unsuitable on clinical/capacity grounds. 137 patients were eligible. 78 were recruited as participants, all of whom completed the study.InterventionPharmacist conducting holistic medication reviews in the study group over a 6-month period.Primary outcome measuresAnonymised medication changes, cost, biochemical monitoring and clinical measurements data were collected. Cost analysis of having a pharmacist as part of the general practice team was calculated.ResultsIn total, 198 potentially inappropriate prescriptions (PIPs), and 163 opportunities for deprescribing were identified; 127 PIPs (64.1%) were actioned; 104 deprescribing opportunities were actioned (63.8%). The pharmacist identified 101 instances in which further investigations were warranted prior to prescription issue, of which 80 were actioned (79.2%). It was calculated that monthly savings of €1252 were made as a result of deprescribing.ConclusionsThis study has shown that the integration of pharmacists within general practice in Ireland is feasible and is an effective means of improving prescribing safety and implementing deprescribing through medication reviews. The combination of safety and cost concerns support taking a holistic approach to deprescribing with the patient. This study highlights the ease with which a pharmacist could integrate into the general practice setting in Ireland and points to how this could be sustainably funded.

Funder

Health Service Executive

Publisher

BMJ

Subject

General Medicine

Reference51 articles.

1. World Health Organisation . The World Medicines Situation [Internet], 2004. Available: https://www.who.int/medicines/areas/policy/world_medicines_situation/en/

2. World Health Organisation . Medication safety in polypharmacy: technical report [Internet], 2019. Available: https://www.who.int/publications/i/item/medication-safety-in-polypharmacy-technical-report

3. What is polypharmacy? A systematic review of definitions

4. National Institute for Health and Care Excellence (NICE) . Multimorbidity and polypharmacy [Internet], 2019. Available: https://www.nice.org.uk/advice/ktt18

5. Polypharmacy: one of the greatest prescribing challenges in general practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3